Absence of p53 mutations and various frequencies of ki-ras exon 1 mutations in rat hepatic tumors induced by different carcinogens

✍ Scribed by Yoshihiko Tokusashi; Ikue Fukuda; Katsuhiro Ogawa

• Publisher: John Wiley and Sons
• Year: 1994
• Tongue: English
• Weight: 638 KB
• Volume: 10
• Category: Article
• ISSN: 0899-1987
• DOI: 10.1002/mc.2940100108

✦ Synopsis

Abstract

Mutations of p53 and Ki‐ras exon 1 were investigated in rat hepatic lesions induced by four kinds of hepatocarcinogenic protocols: continuous feeding of 3′‐methyl‐4‐dimethylaminoazobenzene (3′‐Me‐DAB), daily intraperitoneal injection of aflatoxin B, (AFB,), and the Soft and Farber regimen (Nature 236:701–703, 1976), in which diethylnitrosamine (DEN) or nitrosomethylurea (NMU) was used as initiating agents. DNA from microdissected tissue sections was amplified by the polymerase chain reaction (PCR) directly using primers for p53 exons 5–8 and Ki‐ras exon 1 and analyzed for mutations by denaturing gradient gel electrophoresis (DGGE) or constant denaturant gel electrophoresis (CDGE). One or both of the p53 PCR primers were located within introns to prevent amplifying the p53 processed pseudogenes. In a total of 59 hepatocellular carcinomas (HCCs), no p53 aberrations were detected, indicating that p53 mutations are not very important in rat hepatic carcinogenesis. On the other hand, Ki‐ras codon 12 mutations were found at low frequency in HCCs, hyperplastic foci, and cholangiof ibroses induced by 3′‐Me‐DAB and by AFB! but not in the lesions induced by the Solt and Farber regimen. Although Ki‐ras codon 12 mutations are generally infrequent in rat hepatic tumors, their incidence thus appears to vary depending on the carcinogen used for their induction. © 1994 Wiley‐Liss, Inc.